Patents
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
09/2004
09/23/2004WO2004014850A3 Substituted aminopyrimidines as neurokinin antagonists
09/23/2004US20040186168 Such as spiroadamantane on one side and 4-substituted spiro-cyclohexyl on other side; structurally simple, nontoxic, easy synthesis, potent parasiticides
09/23/2004US20040186140 Cyclic derivatives as modulators of chemokine receptor activity
09/23/2004US20040186134 Inhibitors of Factor Xa are useful as anticoagulants in the treatment of cardiovascular disorders associated with thromboses; e.g., 1,1-dimethylethyl 1-[1-(-2-(-3-[2-(5-Chloro-thiophen-2-yl)-ethenesulfonylamino]-2-oxo-piperidin-1-yl)-acetyl)-pyrrolidin-2- yl-methyl]-pyrrolidin-3-yl}-methyl-carbamate
09/23/2004US20040186126 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
09/23/2004DE10311300A1 New 2-alkoxy-4-halo-6-alkylphenyl-substituted (hetero)cyclic ketoenols, useful as total or selective herbicides and pesticides, e.g. insecticides, acaricides and nematocides for plant protection
09/22/2004EP1460078A1 3,4-alkylenedioxythiophendioles and electrically conducting polymers thereof for use in capacitors
09/22/2004EP1458784A1 3,4-alkylenedioxythiophene compounds and polymers thereof
09/22/2004EP1458723A1 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function
09/22/2004EP1458707A2 New compounds
09/22/2004EP1192165B1 Substituted heterocycle fused gamma-carbolines
09/22/2004EP1189904B1 Substituted heterocycle fused gamma-carbolines
09/22/2004EP1060266A4 Method for identifying mismatch repair glycosylase reactive sites, compound and uses thereof
09/22/2004EP0912908B1 Novel photochromic heterocyclic fused indenonaphthopyrans
09/22/2004CN1531534A 2-heteroaryl-3,4-dihydro-2H-pyrrole derivatives and use thereof as pesticides
09/22/2004CN1531445A Biotin-derivatives and their conjugates with chelating agents
09/22/2004CN1531444A Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using same
09/22/2004CN1531425A Urea derivatives as integrin alpha 4 antagonists
09/22/2004CN1167681C Condensed indoline derivatives and their use as 5HT, in particular 5HT2 receptor ligands
09/22/2004CN1167680C Fused-ring compounds and use thereof as drugs
09/16/2004WO2004078763A1 Thiadibenzoazulene derivatives for the treatment of inflammatory diseases
09/16/2004WO2004078758A1 Novel fused heterocycles and uses thereof
09/16/2004WO2004078742A1 Thiolactones
09/16/2004WO2004078712A2 Isoquinoline derivatives and methods of use thereof
09/16/2004WO2004078119A2 Substituted thiophenes with antibacterial activity
09/16/2004WO2004064972A9 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
09/16/2004WO2004047837A3 Beta-blockers having antioxidant and nitric oxide-donor activity
09/16/2004WO2004028459A3 Piperidine derivatives
09/16/2004US20040180947 Sulfonamide compounds and pharmaceutical use thereof
09/16/2004US20040180939 Acetyl 2-hydroxy-1, 3-diaminoalkanes
09/16/2004US20040180922 Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
09/16/2004US20040180907 for use in fertility regulating therapies
09/16/2004US20040180883 Central nervous system disorders; such as 7-{2-[4-(6-Fluorobenzothiophen-3-yl)-2-methylpiperazin-1-yl]ethyl}-4,5-dihydro-7H-thieno[2,3-c]pyran-2-carboxamide
09/16/2004US20040180873 Thieno{2,3-d}pyrimidines with combined lh and fsh agonistic activity
09/16/2004DE10301923B3 Verfahren und Zwischenprodukte zur Herstellung von Olanzapin Processes and intermediates for the preparation of olanzapine
09/16/2004CA2517847A1 Thiadibenzoazulene derivatives for the treatment of inflammatory diseases
09/16/2004CA2517523A1 Substituted thiophenes with antibacterial activity
09/16/2004CA2517358A1 Isoquinoline derivatives and methods of use thereof
09/15/2004EP1457488A1 Intermediates for use in the preparation of urea compounds having muscarinic receptor antagonist activity
09/15/2004EP1456657A1 Tagged microparticle compositions and methods
09/15/2004EP1456172A1 Pyrrolidine-2-ones as factor xa inhibitors
09/15/2004EP1294729B1 2-aminoalkyl-thieno[2,3-d]pyrimidines
09/14/2004US6790965 Inhibition of carbonic anhydrase isozymes; glaucoma
09/14/2004US6790844 Muscle relaxants; antiserotonine agent
09/10/2004WO2004041776A3 SULFONYLAMINOVALEROLAC TAMS AND DERIVATIVES THEREOF AS FACTOR Xa INHIBITORS
09/10/2004WO2004014352A3 Methods for treating carbonic anhydrase mediated disorders
09/09/2004US20040176605 Compounds as antumor agents or immunosuppressants
09/09/2004US20040176603 Substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions
09/09/2004US20040176458 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
09/09/2004US20040176438 Novel mono- and di-fluorinated beozothiepine copmunds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake
09/09/2004US20040176362 Matrix metalloproteinase inhibitors, treatment of tumor necrosis factor mediated diseases; autoimmune and neurodegenerative disorders; anticarcinogenic and antiinflammatory agents
09/09/2004US20040176324 Derivatives of 4,7-ethanothiopyrano[3,4-c]pyrrole-1,3-(2H)-dione, 4,7-epoxy-1H-isoindole-1,3(2H)-dione, and/or 4,7-ethano-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-dione derivatives; autoimmune diseases; anticarcinogenic agents
09/09/2004US20040175638 Simple synthesis; high charge mobility; close packed, stable morphology; thin films; ordered mesogenic, crosslinkable monomers
09/08/2004EP1453841A1 Technetium or rhenium complexes, radiopharmaceutical products comprising them
09/08/2004EP1453789A2 N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/08/2004EP1268408B1 Arthropodicidal carboxanilides
09/08/2004EP0763009B1 Photocleavable conjugates for the detection and isolation of biomolecules
09/08/2004CN1527712A Active ingredient combination for medicamentous therapy of nicotine dependency
09/08/2004CN1165303C DNA binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents
09/07/2004US6787548 Cardiovascular insufficiency and erectile dysfunction; 3-(4-(3-chloro-4-hydroxybenzylamino) benzo(4,5)thieno(2,3-d)pyrimidin-2-yl)propionic acid
09/07/2004US6787541 Thieno-and furopyrimidine derivatives as A2A-receptor antagonists
09/07/2004CA2105709C Substituted cyclohexane derivatives, processes for their preparation and the use of the compounds for treating diseases
09/02/2004WO2004074287A1 Novel compounds
09/02/2004WO2004074270A2 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
09/02/2004WO2004074215A1 Process for preparation of clopidogrel, its salts and pharmaceutical compositions
09/02/2004US20040171881 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/02/2004US20040171847 From a pyrrolidinone compound; coloring high molecular weight material
09/02/2004US20040171644 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
09/02/2004US20040171623 thieno[2,3-d]pyrimidinediones; modulation of autoimmune disease
09/02/2004US20040171606 antagonism/inhibition, of the D3 receptor; substance abuse.
09/02/2004US20040171590 Bicyclic pyrimidine and pyrimidine derivatives useful as anticancer agents
09/02/2004US20040171543 Matrix metalloproteinase inhibitors and methods for identification of lead compounds
09/02/2004US20040170866 Cyclic tertiary amine compound and organic electroluminescent device containing the compound
09/02/2004DE10305984A1 Salze organischer Säuren mit Clopidogrel und deren Verwendung zur Herstellung phamazeutischer Formulierungen Salts of organic acids with clopidogrel and to the use thereof for the preparation of formulations phamazeutischer
09/02/2004CA2516235A1 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
09/01/2004EP1452526A1 Indole compound and medicinal use thereof
09/01/2004EP1452524A1 "2-oxo-1-pyrrolidine derivative and its pharmaceutical uses"
09/01/2004EP1451195A1 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
09/01/2004EP1450801A2 2-aminoquinoline compounds
08/2004
08/31/2004US6784201 Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
08/31/2004US6784197 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
08/31/2004US6784190 Integrin receptor antagonists
08/31/2004US6784174 Inhibitors of the production of cytokines such as tnf
08/26/2004WO2004073081A1 Switching element
08/26/2004WO2004073080A1 Rectifier element
08/26/2004WO2004072085A2 Salt of a sulfonic acid containing clopidogrel and use thereof for the production of pharmaceutical formulations
08/26/2004WO2004072083A1 Benzamide derivatives as oxytocin agonists and vasopressin antagonists
08/26/2004WO2004072074A1 Pyrrolidinohydrochinazolines
08/26/2004WO2004072051A1 Isoxazole compounds as inhibitors of heat shock proteins
08/26/2004WO2004071460A2 Cyclic derivatives as modulators of chemokine receptor activity
08/26/2004WO2004052288A3 2-nh-heteroarylimidazoles with antibacterial activity
08/26/2004WO2004018438A3 Microbiocidal (e.g. fungicidal) 1,2,3-triazole derivatives
08/26/2004US20040167160 Skin disorders; controlling cell differentiation; antidiabetic agents; cardiovascular disorders; anticancer agents; central nervous system disorders
08/26/2004US20040167145 moderator of cholinergic agent; mixture of acetylcholinesterase inhibitors and opioiod receptor blockers
08/26/2004US20040167141 Anticancer agents; antidiabetic agents; Alzheimer's disease
08/26/2004US20040167138 Antiischemic agents; brain disorders
08/26/2004US20040167123 Anti-infective agents
08/26/2004CA2513220A1 Benzamide derivatives as oxytocin agonists and vasopressin antagonists
08/25/2004EP1449844A1 benzamide derivatives as oxytocin agonists and vasopressin antagonists
08/25/2004EP1448566A2 Chemokine receptor antagonists and methods of use thereof